These devices facilitate manual x-ray contrast media injections during angiography procedures performed in the cardiac catheterization laboratory and interventional radiology suite.
Under the terms of the agreement, Covidien immediately obtains all assets related to these two Pinyons product lines, including all intellectual property, current and future product designs and regulatory filings and approvals. The injection and inflation devices have received clearance from the FDA.
Shawn Fojtik, president and CEO of Pinyons Medical, said: Our products are specifically designed to provide ergonomic and mechanical advantages over angiographic control syringes, especially during interventional procedures requiring repetitive, small-volume contrast media injections.